Medine GmbH 13D/13G Filings for BioNTech SE (BNTX)

Medine GmbH 13D and 13G filings for BioNTech SE:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-02-14
07:26 am
Sale
2023-12-31 13G BioNTech SE
BNTX
Medine GmbH 41,295,728
17.400%
-966,311decrease
(-2.29%)
Filing
2023-02-21
7:17 pm
Purchase
2022-12-31 13G BioNTech SE
BNTX
Medine GmbH 42,262,039
17.400%
756,186increase
(+1.82%)
Filing
2022-02-14
4:23 pm
Sale
2021-12-31 13G BioNTech SE
BNTX
Medine GmbH 41,505,853
17.110%
-157,577decrease
(-0.38%)
Filing
2021-02-16
4:06 pm
Sale
2020-12-31 13G BioNTech SE
BNTX
Medine GmbH 41,663,430
16.920%
-27,540decrease
(-0.07%)
Filing